These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 16272262

  • 1. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.
    Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, Dubosq-Bidot L, Sebillon P, Mannens MM, Guicheney P, Wilde AA.
    J Med Genet; 2005 Nov; 42(11):863-70. PubMed ID: 16272262
    [Abstract] [Full Text] [Related]

  • 2. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
    van der Werf C, Nederend I, Hofman N, van Geloven N, Ebink C, Frohn-Mulder IM, Alings AM, Bosker HA, Bracke FA, van den Heuvel F, Waalewijn RA, Bikker H, van Tintelen JP, Bhuiyan ZA, van den Berg MP, Wilde AA.
    Circ Arrhythm Electrophysiol; 2012 Aug 01; 5(4):748-56. PubMed ID: 22787013
    [Abstract] [Full Text] [Related]

  • 3. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.
    Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM, Klug D, Hayashi M, Takatsuki S, Villain E, Kamblock J, Messali A, Guicheney P, Lunardi J, Leenhardt A.
    Circulation; 2009 May 12; 119(18):2426-34. PubMed ID: 19398665
    [Abstract] [Full Text] [Related]

  • 4. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms.
    Laitinen PJ, Swan H, Kontula K.
    Eur J Hum Genet; 2003 Nov 12; 11(11):888-91. PubMed ID: 14571276
    [Abstract] [Full Text] [Related]

  • 5. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction.
    Ohno S, Omura M, Kawamura M, Kimura H, Itoh H, Makiyama T, Ushinohama H, Makita N, Horie M.
    Europace; 2014 Nov 12; 16(11):1646-54. PubMed ID: 24394973
    [Abstract] [Full Text] [Related]

  • 6. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
    Kontula K, Laitinen PJ, Lehtonen A, Toivonen L, Viitasalo M, Swan H.
    Cardiovasc Res; 2005 Aug 15; 67(3):379-87. PubMed ID: 15913575
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.
    Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, Früh A, Edvardsen T, Kongsgård E, Leren TP, Amlie JP.
    Europace; 2010 Mar 15; 12(3):417-23. PubMed ID: 20106799
    [Abstract] [Full Text] [Related]

  • 9. Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by RYR2 Mutations.
    Miyata K, Ohno S, Itoh H, Horie M.
    Intern Med; 2018 Jul 01; 57(13):1813-1817. PubMed ID: 29434162
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.
    Swan H, Laitinen P, Kontula K, Toivonen L.
    J Cardiovasc Electrophysiol; 2005 Feb 01; 16(2):162-6. PubMed ID: 15720454
    [Abstract] [Full Text] [Related]

  • 12. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
    Marks AR, Priori S, Memmi M, Kontula K, Laitinen PJ.
    J Cell Physiol; 2002 Jan 01; 190(1):1-6. PubMed ID: 11807805
    [Abstract] [Full Text] [Related]

  • 13. [Genetic of catecholaminergic polymorphic ventricular tachycardia: basic concepts].
    Medeiros-Domingo A.
    Arch Cardiol Mex; 2009 Dec 01; 79 Suppl 2():13-7. PubMed ID: 20361477
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves.
    Paavola J, Viitasalo M, Laitinen-Forsblom PJ, Pasternack M, Swan H, Tikkanen I, Toivonen L, Kontula K, Laine M.
    Eur Heart J; 2007 May 01; 28(9):1135-42. PubMed ID: 17347175
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Catecholaminergic polymorphic ventricular tachycardia].
    Leren IS, Haugaa KH, Edvardsen T, Anfinsen OG, Kongsgård E, Berge KE, Leren TP, Amlie JP.
    Tidsskr Nor Laegeforen; 2010 Jan 28; 130(2):139-42. PubMed ID: 20125202
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.